Diagnostic tests based on the detection of DNA from harmful organisms in clinical samples have revolutionized veterinary medicine in the last decades. Currently, diagnostic panels for several vectorborne diseases (VBDs) are available through universities and private labs in the USA and abroad. Continue reading “Research Update CHF 02528 EY3: Developing a Next Generation Sequencing Diagnostic Platform for Tick-Borne Diseases”
Research Update CHF 02528 MY2: Developing a Next Generation Sequencing Diagnostic Platform for Tick-Borne Diseases
Despite the wide availability of tick-borne disease panels at laboratories in the USA and abroad, most results from sick dogs are negative, which frustrates veterinarians and dog owners trying to reach a definitive diagnosis. Continue reading “Research Update CHF 02528 MY2: Developing a Next Generation Sequencing Diagnostic Platform for Tick-Borne Diseases”
Research Update CHF 02528 MY3: Developing a Next Generation Sequencing Diagnostic Platform for Tick-Borne Diseases
Despite the wide availability of tick-borne disease panels at laboratories in the USA and abroad, most results from sick dogs are negative, which frustrates veterinarians and dog owners trying to reach a definitive diagnosis. Continue reading “Research Update CHF 02528 MY3: Developing a Next Generation Sequencing Diagnostic Platform for Tick-Borne Diseases”
Research Update End-yr 2 CHF 02528: Developing a Next Generation Sequencing Diagnostic Platform for Tick-Borne Diseases
Diagnostic tests based on the detection of DNA from harmful organisms in clinical samples have revolutionized veterinary medicine in the last decades. Currently, diagnostic panels for several vectorborne diseases (VBDs) are available through universities and private labs in the USA and abroad. However, the vast majority of results from sick dogs are negative, which frustrates veterinarians and dog owners trying to reach a definitive diagnosis.
Research Update End-Year 3 02309-T: Targeting the Cancer Epigenome: The Effect of Specific Histone Lysine Methyltransferase Inhibition in Canine B-Cell Lymphoma
Update on targeting epigenome for treatment of B-cell lymphoma from Dr McCleary-Wheeler.
Research Update End-Year-1 CHF-02528: Developing a Next Generation Diagnostic Platform for TBD
Research update for improving diagnostics for Tick-Borne Disease.
Research Update Mid-Year-1 CHF-02528: Developing a Next Generation Diagnostic Platform for TBD
Research update for improving diagnostics for Tick-Borne Disease.
Research Update Mid-Year-2 CHF-02292: Broad-Range Detection of Canine Tick-Borne Disease and Improved Diagnostics Using Next-Generation Sequencing
Research update for expansion and improvement of diagnostics for definitive diagnosis of tick-borne disease in dogs.
Update Mid-Year 2 – Mapping Genetic Risk Factors for Canine Hip Dysplasia
Update from the middle of year 2 of research underway by Dr. Iivanainen of University of Helsinki to hopefully lead to a genetic test to aid breeders in controlling hip dysplasia.
Continue reading “Update Mid-Year 2 – Mapping Genetic Risk Factors for Canine Hip Dysplasia”
Final Results on Beyond the Genome
Final results on Dr. Robert K Wayne’s work investigating DNA methylation and its regulation of gene expression in normal and pathological states.
